U.S. Food and Drug Administration (FDA) · United States

FDA Non-Compliant Prescription Drug Advertising

Rx drug ads must present risks with fair balance, include a brief summary or major statement, keep broadcast risk statements clear, conspicuous and neutral, stay within the label, and compounded-drug ads must not imply FDA approval or brand equivalence.

21 U.S.C. 352(a), (n), (bb); 21 CFR 202.1(e)(1), (e)(5), (e)(6), (e)(7)

What is FDA Non-Compliant Prescription Drug Advertising?

Rx drug ads must present risks with fair balance, include a brief summary or major statement, keep broadcast risk statements clear, conspicuous and neutral, stay within the label, and compounded-drug ads must not imply FDA approval or brand equivalence. Apply to US prescription drug DTC and HCP advertising across all channels, including telehealth and compounded-drug promotion.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients, health_professionals · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

Rx drug ads must present risks with fair balance, include a brief summary or major statement, keep broadcast risk statements clear, conspicuous and neutral, stay within the label, and compounded-drug ads must not imply FDA approval or brand equivalence.

How can marketing teams comply?

Apply to US prescription drug DTC and HCP advertising across all channels, including telehealth and compounded-drug promotion.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 352(a), (n), (bb); 21 CFR 202.1(e)(1), (e)(5), (e)(6), (e)(7)
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, patients, health_professionals

Frequently asked questions

What is FDA Non-Compliant Prescription Drug Advertising?

Rx drug ads must present risks with fair balance, include a brief summary or major statement, keep broadcast risk statements clear, conspicuous and neutral, stay within the label, and compounded-drug ads must not imply FDA approval or brand equivalence.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients, health_professionals · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan